Capitolis Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-42,234
Closed -$2.36M 503
2021
Q4
$2.36M Buy
+42,234
New +$2.32M 0.01% 392
2021
Q3
Sell
-12,731
Closed -$805K 459
2021
Q2
$805K Hold
12,731
0.01% 310
2021
Q1
$812K Hold
12,731
0.01% 317
2020
Q4
$667K Buy
+12,731
New +$628K 0.01% 441

Other funds holding XRAY

Capitolis Advisors's XRAY Position: Q1 2022 in Review

Capitolis Advisors sold out of Dentsply Sirona (XRAY) in Q1 2022, closing a stake of 42,234 shares — an estimated $2.36M sold.

Capitolis Advisors first reported a position in XRAY in Q4 2020 and held it in 4 quarters. The position peaked at $2.36M in Q4 2021. 536 funds tracked by Wall St. Rank hold XRAY as of Q1 2022.

  • Capitolis Advisors reported no remaining Dentsply Sirona position as of Q1 2022 after selling out during the quarter.
  • Capitolis Advisors sold 42,234 Dentsply Sirona shares in Q1 2022, an estimated $2.36M.
  • Capitolis Advisors first reported a position in Dentsply Sirona in Q4 2020 and held it in 4 quarters.
  • Capitolis Advisors's Dentsply Sirona position peaked at $2.36M in Q4 2021.
  • 536 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2022.

Based on Capitolis Advisors's 13F filing for Q1 2022, filed 12 May 2022.